Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. [provided by RefSeq, Sep 2008]
GFPT1 (Glutamine--Fructose-6-Phosphate Transaminase 1) is a Protein Coding gene. Diseases associated with GFPT1 include Myasthenic Syndrome, Congenital, 12 and Congenital Myasthenic Syndrome. Among its related pathways are Transport to the Golgi and subsequent modification and Synthesis of substrates in N-glycan biosythesis. Gene Ontology (GO) annotations related to this gene include carbohydrate binding and glutamine-fructose-6-phosphate transaminase (isomerizing) activity. An important paralog of this gene is GFPT2.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity | IBA | 21873635 |
GO:0008483 | transaminase activity | IEA | -- |
GO:0016740 | transferase activity | IEA | -- |
GO:0097367 | carbohydrate derivative binding | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005829 | cytosol | TAS | -- |
GO:0070062 | extracellular exosome | HDA | 20458337 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Amino sugar and nucleotide sugar metabolism | ||
2 | Unfolded Protein Response (UPR) | ||
3 | Synthesis of substrates in N-glycan biosythesis | ||
4 | Metabolism of proteins | ||
5 | Glucose / Energy Metabolism |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006002 | fructose 6-phosphate metabolic process | TAS,IBA | 21873635 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | IBA | 21873635 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | TAS | -- |
GO:0006112 | energy reserve metabolic process | TAS | 1460020 |
GO:0006487 | protein N-linked glycosylation | IBA | 21873635 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Famotidine | Approved | Pharma | Histamine H2-receptor antagonist | 70 | ||
Glutamic acid | Approved | Nutra | Full agonist, Agonist | 281 | ||
L-Glutamine | Approved, Investigational | Nutra | Full agonist, Agonist | 0 | ||
glucosamine 6-phosphate | Experimental | Pharma | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
Fructose 6-phosphate |
|
643-13-0 |
|
This gene was present in the common ancestor of eukaryotes.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
chimpanzee (Pan troglodytes) |
Mammalia | GFPT1 33 32 |
|
OneToOne | |
oppossum (Monodelphis domestica) |
Mammalia | GFPT1 33 |
|
OneToOne | |
platypus (Ornithorhynchus anatinus) |
Mammalia | GFPT1 33 |
|
OneToOne | |
cow (Bos Taurus) |
Mammalia | GFPT1 33 32 |
|
OneToOne | |
dog (Canis familiaris) |
Mammalia | GFPT1 33 32 |
|
OneToOne | |
mouse (Mus musculus) |
Mammalia | Gfpt1 17 33 32 |
|
||
rat (Rattus norvegicus) |
Mammalia | Gfpt1 32 |
|
||
chicken (Gallus gallus) |
Aves | GFPT1 33 32 |
|
OneToOne | |
tropical clawed frog (Silurana tropicalis) |
Amphibia | gfpt1 32 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | gfpt1-prov 32 |
|
||
zebrafish (Danio rerio) |
Actinopterygii | CU929036.1 33 |
|
OneToMany | |
gfpt1 33 32 |
|
OneToMany | |||
fruit fly (Drosophila melanogaster) |
Insecta | Gfat2 33 34 |
|
ManyToMany | |
Gfat1 33 34 |
|
ManyToMany | |||
worm (Caenorhabditis elegans) |
Secernentea | F22B3.4 33 34 |
|
ManyToMany | |
F07A11.2 33 |
|
ManyToMany | |||
F07A11.2b 34 |
|
|
|||
F07A11.2a 34 |
|
|
|||
baker's yeast (Saccharomyces cerevisiae) |
Saccharomycetes | GFA1 33 |
|
OneToMany | |
rice (Oryza sativa) |
Liliopsida | Os.18609 32 |
|
||
sea squirt (Ciona savignyi) |
Ascidiacea | -- 33 |
|
OneToMany | |
Cin.2377 32 |
|
||||
sea squirt (Ciona intestinalis) |
Ascidiacea | Cin.2377 32 |
|
SNP ID | Clin | Chr 02 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs1011196447 | pathogenic, Congenital myasthenic syndrome 12 | 69,354,314(-) | T/C | intron_variant, splice_acceptor_variant | |
rs10185336 | benign, Congenital Myasthenic Syndrome, Recessive | 69,323,520(-) | G/A | 3_prime_UTR_variant, genic_downstream_transcript_variant | |
rs10198150 | benign, Congenital Myasthenic Syndrome, Recessive | 69,323,879(-) | T/C | 3_prime_UTR_variant, genic_downstream_transcript_variant | |
rs10198171 | benign, Congenital Myasthenic Syndrome, Recessive | 69,323,920(-) | T/A/C | 3_prime_UTR_variant, genic_downstream_transcript_variant | |
rs1024585946 | Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542] | 69,329,693(-) | G/A | coding_sequence_variant, missense_variant |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv2720174 | CNV | deletion | 23290073 |
esv33940 | CNV | loss | 17666407 |
esv3591182 | CNV | loss | 21293372 |
nsv1116383 | CNV | deletion | 24896259 |
nsv834252 | CNV | loss | 17160897 |
nsv979015 | CNV | duplication | 23825009 |
Disorder | Aliases | PubMed IDs |
---|---|---|
myasthenic syndrome, congenital, 12 |
|
|
congenital myasthenic syndrome |
|
|
congenital myasthenic syndromes with glycosylation defect |
|
|
myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency |
|
|
heart sarcoma |
|
|